Riley Arseneau is a fourth-year PhD Student investigating the correlations between genetics, immune cells, and pancreatic cancer in the Boudreau lab at Dalhousie University.

Melis is a PhD candidate in the Pathology Doctoral Program at Dalhousie University. With a background in bioinformatics, statistics, and genomics, she is investigating the environmental and genetic drivers of cancer and complex genetic diseases. Her current work utilizes a dual approach to combine multi-omic pipelines with clinical genetics to advance understanding of arsenic-induced lung pathologies, with a focus on improving diagnosis and prevention of these diseases in Nova Scotia and across Canada.

Dr. Gaston is a Clinical Bioinformatician with Nova Scotia Health and an Assistant Professor in the Department of Pathology at Dalhousie University. He completed a PhD with Dr. Andrew Roger in the molecular evolution of protein function and a Post-Doctoral Fellowship with Dr. Karen Bedard in the genomics of rare hereditary diseases in Atlantic Canada, both at Dalhousie University. Dr. Gaston’s research focuses on the application of bioinformatics and genomics to cancer, with a focus on clinical testing applications and large-scale research. Dr. Gaston is the bioinformatics co-lead for the Atlantic Cancer Consortium part of the Terry Fox Research Institute’s Marathon of Hope Cancer Centres Network initiative.